Open AccessImpact of Vitamin D Deficiency on the Pathogenesis of Polycystic Ovary Syndrome
Author(s) -
Noor Majid Raheem,
Bushra Hassan Marouf
Publication year - 2022
Publication title -
al-rafidain journal of medical sciences.
Language(s) - English
Resource type - Journals
ISSN - 2789-3219
DOI - 10.54133/ajms.v2i.53
Subject(s) - polycystic ovary , medicine , hirsutism , endocrinology , ovulation , vitamin , vitamin d and neurology , body mass index , physiology , androgen , vitamin d deficiency , animal studies , hormone , obesity , insulin resistance
There are many metabolic and hormonal factors related to polycystic ovary syndrome (PCOS) that can be affected by vitamin D3 supplementation. To find clinical trials, in vivo studies, and in vitro studies that met the review's inclusion and exclusion criteria, we searched many databases. PCOS women's ovulation and metabolic parameters were examined in relation to the effects of vitamin D3 treatment on PCOS risk variables such as seasonal changes in body mass index, and obesity. The current review included twenty-five articles. Vitamin D3(25-hydroxy vitamin D) levels were significantly lower in the PCOS group than in the control group, and lipid profile and androgen hormone levels were significantly higher in the PCOS group, resulting in increased cardiovascular events and exaggerated hirsutism. According to the majority of research, vitamin D3 plays a beneficial role in decreasing the pathophysiology of PCOS, notably in restoring ovulation, which ultimately improves fertility. Although other studies found no effect on lipid profile, there was a minor effect on reducing cardiovascular risks. The response of patients to vitamin D3 was influenced by the dose administered and the study's methodology. In conclusion, vitamin D3 had a good effect on the pathophysiology of PCOS in the majority of investigations.